Valeo Pharma (TSE:VPH) Reaches New 1-Year Low at $0.05

Valeo Pharma Inc. (TSE:VPH)’s share price reached a new 52-week low during trading on Thursday . The company traded as low as C$0.05 and last traded at C$0.05, with a volume of 55000 shares traded. The stock had previously closed at C$0.06.

Valeo Pharma Trading Down 9.1 %

The firm has a market capitalization of C$4.93 million, a price-to-earnings ratio of -0.16 and a beta of 2.38. The firm has a 50 day moving average price of C$0.08 and a two-hundred day moving average price of C$0.11.

Valeo Pharma (TSE:VPH) last posted its earnings results on Thursday, September 12th. The company reported C($0.08) earnings per share for the quarter. The company had revenue of C$12.60 million for the quarter.

About Valeo Pharma

Valeo Pharma Inc, a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada. Its product portfolio includes Enerzair Breezhaler, a LABA/LAMA/ICS fixed triple dose asthma drug; Atectura Breezhaler, a LABA/ICS dual combination asthma drug; Redesca, to treat and prevent deep vein thrombosis and pulmonary embolism; Onstryv, for the treatment of Idiopathic Parkinson's disease; M-Eslon, extended-release morphine sulphate used for pain management; and Yondelis, a soft tissue sarcoma.